Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Catapult Healthcare: Traveling Nurse Agency Recruitment Is on the Rise (Part 1 of 2)

Choosing an agency as a registered nurse can be a daunting task. According to Nurse.org, “Hospitals are trying to cut costs by reducing the number of travel nurses and renegotiating contracts with staffing agencies, but some agencies are still making big promises to travel nurses that can make the whole situation seem like a bait…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Choosing an agency as a registered nurse can be a daunting task. According to Nurse.org, “Hospitals are trying to cut costs by reducing the number of travel nurses and renegotiating contracts with staffing agencies, but some agencies are still making big promises to travel nurses that can make the whole situation seem like a bait and switch.”

Gabrielle Bejarano sat down with Paul Shoe, RN contracted through Catapult Healthcare; Suzanne Raymond, National Recruiter at Catapult Healthcare; and Shannon Kanakaole, Recruiting Operations Manager at Catapult Healthcare, to discuss recruiting best practices and how to work effectively with an agency, in Part 1 of a 2-Part podcast series.

“Communication and transparency are at the forefront of the relationship between the agency and the provider,” said Kanakaole. Nurses need to give recruiters clear direction on what they want and expect from a job. Recruiters need to understand the full range of responsibilities and expectations of the roles they are filling to ensure they are finding the best candidate.

“From the initial call, the first and most important thing is understanding the external factors of where they need to be for their next position or assignment,” said Kanakaole. Recruiters need to be clear on the top three priorities of their candidates. Establishing clarity on must-haves and nice-to-haves ensures recruiters can meet candidates’ needs and create a foundation of trust in the relationship. For nurses, that means knowing their desires and communicating them to a recruiter effectively.

As a nurse coming to an agency, Shoe recommended, “make sure all paperwork is up to date” including everything from licenses, medical records, shots, and vaccines. “The more you have ready to go, the quicker we can get you started after an offer,” said Raymond. It streamlines and simplifies the entire process. Once hired, nurses should continue to have open, honest, and frequent conversations with their recruiters. Maintaining the relationship will help when issues or conflicts need to be addressed.

Listen in to learn more about what to look for when seeking agency representation, how to work successfully with an agency, the role of communications, the changing landscape of the traveling nurse industry, and more. And don’t forget to come back for Part II.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512